Ovid Therapeutics Inc. (OVID)
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $7.3M
- Net income
- -$17.4M
- Total assets
- $150.9M
- Market cap
- $447.9M
- Operating margin
- -585.2%
- Net margin
- -240.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $7.3M
- Operating expenses
- $49.7M
- Operating income
- -$42.4M
- Income tax
- $0
- Net income
- -$17.4M
Balance sheet
- Total assets
- $150.9M
- Current assets
- $74.4M
- Total liabilities
- $20.3M
- Current liabilities
- $8.3M
- Shareholders’ equity
- $130.7M
Cash flow
- Operating cash flow
- -$38.3M
- Investing cash flow
- -$49.9M
- Financing cash flow
- $75.2M
- Net cash flow
- -$13.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $447.9M
- Shares outstanding
- 192.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 5, 2017
Ovid Therapeutics Inc. (OVID) Stock Price
- Reported a net loss of $17.4M in FY2025.
- Revenue declined 97% from FY2021 to FY2025.
- Trading 21% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Ovid Therapeutics Inc..
Write a review
News about Ovid Therapeutics Inc.
News & sentiment via Polygon.io
Ovid Therapeutics Inc.: frequently asked questions
Is Ovid Therapeutics Inc. an American company?
Ovid Therapeutics Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Ovid Therapeutics Inc. headquartered?
Ovid Therapeutics Inc. is headquartered in New York, New York, United States.
Is Ovid Therapeutics Inc. publicly traded?
Yes — Ovid Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol OVID on the NASDAQ.
What does Ovid Therapeutics Inc. do?
Ovid Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
